Last reviewed · How we verify
NCT05318885
The Effect of Nebulization Positions in Asthmatic Children
NA trial testing A Randomized Controlled Study in Asthma Attack in 86 participants. Completed in 20 February 2020.
20 February 2020
Quick facts
| Lead sponsor | Istanbul University - Cerrahpasa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 86 |
| Start date | 15 October 2019 |
| Primary completion | 20 February 2020 |
| Estimated completion | 20 February 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- A Randomized Controlled Study
Conditions studied
- Asthma Attack — all drugs for Asthma Attack →
- Asthma in Children — all drugs for Asthma in Children →
- Asthma Acute — all drugs for Asthma Acute →
- Asthma — all drugs for Asthma →
Sponsor
Istanbul University - Cerrahpasa
Who can join
Adults 6 to 11, any sex, with Asthma Attack or Asthma in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to establish the effect on pulse rate, oxygen saturation, respiratory rate, pain and anxiety levels of Fowler's and the forward-leaning positions during nebulization in children experiencing asthma attacks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of Forward-Leaning and Fowler Position: Effects on Vital Signs, Pain, and Anxiety Scores in Children With Asthma Exacerbations.
Kaş Alay G, Yıldız S. · · 2024 · PMID 38719226 · DOI 10.4187/respcare.11752
Verify or expand the search:
- PubMed search for NCT05318885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma Attack
Currently open trials in the same condition.
- NCT07129616 — Remote Monitoring of Asthma in Children and Young People · recruiting
- NCT07052942 — Individualizing Treatment for Asthma in Primary Care (Full Study) · Phase 4 · recruiting
- NCT06734793 — Wearable Electronic Breath Sound Sensing Device · recruiting
- NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting
- NCT06137040 — Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation · EARLY_PHASE1 · recruiting
Other Istanbul University - Cerrahpasa trials
Trials by the same sponsor.
- NCT07588685 — Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Co · not yet recruiting
- NCT07370025 — The Effect of Lullaby During Bath Time on Mother-Infant Bonding, Postpartum Depression, and Parental Self-Efficacy in In · NA · not yet recruiting
- NCT07378449 — The Effect of Hand Exercise Hoops on Labour Pain · NA · not yet recruiting
- NCT07293000 — Evaluating Two Nursing Interventions to Prevent Urinary Retention After Spinal Anesthesia · NA · not yet recruiting
- NCT07562880 — Validity and Reliability of the Exercise-Related Health Beliefs Attitude Scale in Geriatric Individuals · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05318885 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul University - Cerrahpasa
- Last refreshed: 8 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing